Ozempic Shows Mental Health Benefits but Poses Risks if Stopped, New Research Warns

Ozempic Shows Mental Health Benefits but Poses Risks if Stopped, New Research Warns

Recent studies from the past week highlight new insights into Ozempic and similar GLP-1 medications for weight loss. Researchers from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia analyzed large-scale data and found that semaglutide, the active ingredient in Ozempic, significantly reduces risks of depression, anxiety, and addiction alongside its weight loss effects. According to their work published in The Lancet Psychiatry, users experienced a 44 percent lower risk of depression and a 38 percent drop in anxiety disorders during treatment periods. Psychiatric hospital visits fell by 42 percent, and substance use disorders decreased by 47 percent compared to times without the medication. The team suggests these benefits may stem from lifestyle changes or direct effects on the brain.

Another study from Washington University School of Medicine, reported by Fox News, warns that stopping GLP-1 drugs like Ozempic quickly erodes heart health gains. Continuous use over three years lowered cardiovascular risk by 18 percent through reductions in cholesterol, blood pressure, inflammation, and insulin resistance. However, quitting for six months raised risk by 4 percent, one year by 14 percent, and two years by 22 percent. Restarting the drugs provided partial protection, only 12 percent, indicating some lasting damage from discontinuation. Lead researcher Ziyad Al-Aly described this as metabolic whiplash, with silent reversals in metabolic health that could lead to heart attacks or strokes.

Oprah Winfrey continues to draw attention for her weight loss transformation using GLP-1 medications. The List reports that recent before-and-after photos from events like the 2025 Tony Awards reveal Ozempic neck, a sagging, crepey skin effect under the jaw due to rapid fat loss outpacing skin adjustment. Winfrey has been seen favoring high-necked outfits to camouflage the loose folds, a common side effect among users.

These developments underscore the dual-edged nature of Ozempic for weight management, offering mental and heart benefits during use but posing challenges with side effects and discontinuation.

Thanks for tuning in, listeners, please subscribe, and remember, this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.

Some great Deals https://amzn.to/49SJ3Qs

For more check out http://www.quietplease.ai

This content was created in partnership and with the help of Artificial Intelligence AI

Avsnitt(74)

GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11 to 16 Percent Results Despite Side Effects

GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11 to 16 Percent Results Despite Side Effects

Recent Cochrane reviews commissioned by the World Health Organization show that blockbuster weight loss drugs like Ozempic deliver substantial results. According to ScienceDaily reporting on February ...

18 Feb 2min

GLP-1 Weight Loss Drugs Show Promise: Semaglutide and Tirzepatide Lead Clinical Reviews in 2026

GLP-1 Weight Loss Drugs Show Promise: Semaglutide and Tirzepatide Lead Clinical Reviews in 2026

Recent news highlights ongoing developments in weight loss treatments like Ozempic, with fresh insights from clinical reviews and patient experiences. On February 11, 2026, Cochrane reviews commission...

14 Feb 3min

Ozempic and Wegovy Weight Loss: Benefits, Risks, and Expert Nutrition Guidance

Ozempic and Wegovy Weight Loss: Benefits, Risks, and Expert Nutrition Guidance

Recent research from the University of Cambridge highlights a key concern with popular weight-loss drugs like Ozempic and Wegovy. These medications sharply reduce appetite, leading to calorie intake d...

11 Feb 2min

GLP-1 Drugs Like Ozempic Transform Weight Loss Landscape in 2026 With Major Health and Industry Implications

GLP-1 Drugs Like Ozempic Transform Weight Loss Landscape in 2026 With Major Health and Industry Implications

In the past week, weight loss drugs like Ozempic, Wegovy, and Mounjaro have reshaped global conversations on obesity, marking 2026 as a potential turning point. Firstpost reports that these GLP-1 drug...

7 Feb 2min

Novo Nordisk CagriSema Outperforms Ozempic in Phase III Trial for Type 2 Diabetes and Weight Loss

Novo Nordisk CagriSema Outperforms Ozempic in Phase III Trial for Type 2 Diabetes and Weight Loss

Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA...

4 Feb 2min

Oprah Endorses GLP-1 Drugs for Weight Loss as Regulators Issue New Safety Guidance on Semaglutide

Oprah Endorses GLP-1 Drugs for Weight Loss as Regulators Issue New Safety Guidance on Semaglutide

Oprah Winfrey has been candid this week about her ongoing use of GLP-1 medications like those containing semaglutide, the active ingredient in Ozempic, for weight management. In recent interviews prom...

31 Jan 2min

GLP-1 Medications Transform Weight Loss Treatment as Medicaid Coverage Remains Inconsistent Across States

GLP-1 Medications Transform Weight Loss Treatment as Medicaid Coverage Remains Inconsistent Across States

The landscape of weight loss treatment in America is shifting dramatically as glucagon-like peptide-one receptor agonists, or GLP-1s, continue to dominate conversations about obesity management. Accor...

28 Jan 2min

Oprah Reveals Ozempic Weight Regain After Stopping Drug, Experts Warn of Lifelong Dependency

Oprah Reveals Ozempic Weight Regain After Stopping Drug, Experts Warn of Lifelong Dependency

Oprah Winfrey shared striking insights this week on her experience with Ozempic, a popular drug known as semaglutide for type two diabetes and weight management. On the Today Show on January 21, 2026,...

24 Jan 2min

Populärt inom Politik & nyheter

svenska-fall
rss-krimstad
aftonbladet-krim
p3-krim
flashback-forever
blenda-2
rss-sanning-konsekvens
politiken
aftonbladet-daily
rss-krimreportrarna
motiv
rss-vad-fan-hande
spar
grans
rss-frandfors-horna
rss-flodet
svd-ledarredaktionen
dagens-eko
olyckan-inifran
spotlight